Want to see TSE:JWEL full AI Analyst Report?
Jamieson Wellness Inc (JWEL) AI Stock Analysis
Jamieson Wellness Inc
(TSX:JWEL)
Score is driven primarily by solid operating performance and improving margins, offset by weaker recent cash conversion/FCF trends and higher leverage. Technicals are supportive due to a strong uptrend, though elevated RSI suggests the move may be extended. Valuation is somewhat premium (P/E ~23.5) with only moderate support from the ~2.22% dividend yield.
Jamieson Wellness Inc (JWEL) vs. iShares MSCI Canada ETF (EWC)
- Market Cap
- CAD 1.89B
- Dividend Yield
- 2.06%
- Average Volume (3M)
- 309.74K
- Price to Earnings (P/E)
- 24.2
- Beta (1Y)
- 0.89
- Revenue Growth
- 14.96%
- EPS Growth
- 35.61%
- Country
- Canada
- Employees
- 891
- Sector
- Consumer Defensive
- Sector Strength
- 62
- Industry
- Packaged Foods
Jamieson Wellness Inc Business Overview & Revenue Model
Company Description
Jamieson Wellness Inc. is a natural health products company involved in the development, manufacturing, marketing, and distribution of its offerings across Canada and internationally. The enterprise operates through two core segments. Its Jamieson Br...
How the Company Makes Money
Jamieson Wellness makes money primarily by selling branded wellness products, especially vitamins, minerals, and supplements, through a mix of domestic and international distribution channels. Its core revenue stream is product sales to retailers and...
Jamieson Wellness Inc Earnings Call Summary
The call conveyed a broadly positive outlook backed by strong top-line growth (branded and consolidated), margin expansion, robust China execution, improved adjusted profitability and shareholder returns (buybacks/dividends). Key near-term headwinds include a decline in strategic partner revenues, higher SG&A (including one-time due diligence costs), and a working-capital build tied to inventory and tariff mitigation. Management provided confident 2026 guidance with continued China and U.S. growth expectations and targets for higher adjusted EBITDA and EPS, suggesting momentum outweighs the manageable operational and investment-related pressures.
Q4-2025 Updates
Positive Updates
Negative Updates
Company Guidance
Management guided 2026 consolidated revenue of $895–$935 million (up ~9% to almost 14%), with Jamieson Brands revenue of $790–$820 million (≈9%–13% growth); by region they forecast China +20%–30%, U.S. +14%–19% (USD), Canada +4%–6%, International +10%–15% (USD), and Strategic Partner revenues returning to growth of +10%–20%. They expect adjusted EBITDA of $174–$181 million (up ~9%–13.4%) with adjusted EBITDA margins ~19.4%, adjusted diluted EPS of $2.08–$2.21 (up 12.5%–19.5%), and cash from operations before working capital of $120–$130 million (up 9%–19%); working capital is expected to increase $25–$35 million and capital expenditures to be approximately $20 million.
Jamieson Wellness Inc Financial Statement Overview
Summary
Operating performance is solid with steady multi-year revenue growth and improving TTM margins (gross ~41.6%, operating ~15.0%, net ~8.7%). However, the balance sheet has become more leveraged (debt-to-equity ~1.0 in TTM vs ~0.61 in 2024), and cash flow quality has weakened with low cash conversion (OCF to net income ~0.37) and declining free cash flow (FCF growth ~-27%).
Income Statement
74PositiveBalance Sheet
62PositiveCash Flow
50Neutral| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 880.58M | 822.06M | 733.78M | 676.17M | 547.37M | 451.03M |
| Gross Profit | 368.77M | 338.33M | 275.61M | 233.56M | 198.34M | 162.44M |
| EBITDA | 152.84M | 135.33M | 114.60M | 108.78M | 100.17M | 90.40M |
| Net Income | 78.57M | 62.44M | 51.91M | 47.88M | 52.81M | 52.08M |
Balance Sheet | ||||||
| Total Assets | 1.23B | 1.22B | 1.21B | 1.14B | 1.11B | 652.48M |
| Cash, Cash Equivalents and Short-Term Investments | 24.31M | 41.23M | 44.79M | 36.86M | 26.24M | 6.78M |
| Total Debt | 477.35M | 472.02M | 308.29M | 462.99M | 400.00M | 149.13M |
| Total Liabilities | 677.34M | 685.52M | 660.41M | 662.38M | 675.67M | 310.45M |
| Stockholders Equity | 509.52M | 485.42M | 505.18M | 438.93M | 431.59M | 342.02M |
Cash Flow | ||||||
| Free Cash Flow | 23.01M | 69.80M | 51.41M | 22.41M | 36.02M | 22.12M |
| Operating Cash Flow | 35.54M | 82.51M | 61.58M | 31.71M | 50.59M | 44.41M |
| Investing Cash Flow | -21.20M | -22.25M | -10.16M | -35.13M | -256.53M | -22.28M |
| Financing Cash Flow | -42.02M | -62.78M | -45.43M | 14.04M | 225.41M | -16.51M |
Jamieson Wellness Inc Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:JWEL, the sentiment is Positive. The current price of 45.54 is above the 20-day moving average (MA) of 45.49, above the 50-day MA of 45.46, and above the 200-day MA of 38.96, indicating a bullish trend. The MACD of 0.08 indicates Positive momentum. The RSI at 62.94 is Neutral, neither overbought nor oversold. The STOCH value of 55.99 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for TSE:JWEL.
Jamieson Wellness Inc Peers Comparison
Overall Rating
- TSE:JWEL66Neutral
TSE:NPRA48Neutral
TSE:BU45Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| TSE:JWEL | 66Neutral | CAD 1.89B | 24.23 | 15.93% | 2.06% | 14.96% | 35.61% |
| Sector * | 62Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% |
| TSE:NPRA | 48Neutral | CAD 32.16M | -26.55 | 30.14% | ― | 32.91% | 55.73% |
| TSE:BU | 45Neutral | CAD 12.19M | -0.82 | 338.06% | ― | 556.85% | -11.49% |
* Consumer Defensive Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| TSE:JWEL | Jamieson Wellness | 45.56 | 11.80 | 34.93% | |
| TSE:BU | Burcon Nutrascience Corporation | 0.90 | -1.44 | -61.54% | |
| TSE:DTEA | Davidstea Inc. | 1.10 | 0.26 | 30.95% | |
| TSE:MOOO.X | Happy Supplements Inc. | 0.35 | -0.19 | -35.19% | |
| TSE:NPRA | Nepra Foods, Inc. | 0.30 | 0.20 | 185.71% |
Jamieson Wellness Inc Corporate Events
Jamieson Wellness Posts Strong Q2 and Agrees to Kirin Takeover
PositiveJamieson Wellness reported a strong second quarter, with consolidated revenue rising 17.4% to $233.8 million and Jamieson Brands up 18.6%, driven by robust consumer demand and successful promotions across Canada, China, the U.S. and other internation...
Kirin to Acquire Jamieson Wellness in C$2.5 Billion All-Cash Deal
PositiveJamieson Wellness Inc. has entered a definitive agreement to be acquired by Japan’s Kirin Holdings Company, Limited in an all-cash transaction valuing the Canadian vitamins maker at about C$2.5 billion on an enterprise basis. Kirin will pay C$4...
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Aug 09, 2026